UNSPSC 51414000: Vasodilator piperidines

Vasodilator drugs made from a family of hexahydropyridines.

UNSPSC 51414000 Vasodilator piperidines (Class) encompasses emergency and clinical medications supplied to state and local health agencies, fire departments, and pharmacy benefit programs. State and local governments procure specific vasodilator and related cardiopulmonary medications under this code for emergency medical services, inpatient hospital use, and pharmacy distribution networks. Issuing bodies include municipal purchasing departments, state health and human services commissions, and multistate cooperative purchasing alliances. The City of Tampa's Purchasing Department, Texas Health and Human Services Commission, and Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) represent the mix of jurisdictions active in this space, ranging from individual city fire rescue operations to statewide pharmacy benefit program administration across multiple participating states.

Geographic activity centers on Florida, Texas, and Minnesota based on recent solicitations. The City of Tampa issued an IFB (Bid No. 26-P-00188) in April 2026 for Advanced Life Support Medications to supply Tampa Fire Rescue, specifying 370 units of Labetalol HCI 100mg vials, 1,810 units of Epinephrine 1:10,000 injections, 330 units of Adenosine 6mg vials, and 1,020 units of Diltiazem 25mg vials with a firm nine-month minimum expiration date, delivery within ten calendar days, and an estimated contract value of $40,000.00 (bids due April 8, 2026, with SLBE sheltered-market designation and 5 percent bid discount up to $10,000). The Texas Health and Human Services Commission posted an RFI (HHS0017013) in March 2026 to gather vendor capability information for a Therapeutic Pharmacy Initiative Direct-to-Manufacturer Prescriptions program, seeking direct-contracting capacity with self-insured employers and state agencies outside traditional PBM and GPO arrangements. MMCAP, administered by Minnesota's Office of State Procurement, issued an RFP (S1070000015802, due March 26, 2026) for generic multi-source pharmaceuticals and OTC products distributed across participating state and local facilities in Minnesota and Oregon, with awards effective July 1, 2026 and contracts managed through three authorized wholesalers (Cencara, Cardinal Health, Morris & Dickson).